Minimally Invasive Benign Hysterectomy

NCT ID: NCT01865929

Last Updated: 2024-03-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

124 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-01-31

Study Completion Date

2013-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A randomised controlled trial comparing hysterectomy by minimally invasive surgical methods; robotic hysterectomy versus vaginal hysterectomy or traditional laparoscopic hysterectomy; outcome and cost analyses.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Laparoscopic surgery is advantageous compared to open surgery in terms of patient morbidity, shorter hospitalization and a more rapid return to daily activities. Robot-assisted laparoscopic surgery have facilitated a higher proportion of minimally invasive surgery first and foremost within gynecologic oncology.It is not clear whether or not this is true for less advanced surgery where a vaginal approach or a traditional laparoscopic approach is possible.

Robot-assisted surgery is associated with additional cost due to investment and more expensive surgical equipment. The study is performed to investigate whether or not performing hysterectomy for benign conditions with robotic surgery will be advantageous in terms of shorter operating time, less complications, less conversions to open surgery, and shorter hospital stay in comparison to other minimally invasive procedures such as vaginal hysterectomy and traditional laparoscopic hysterectomy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Menorrhagia Metrorrhagia Uterine Fibroids Cervical Dysplasia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Robotic hysterectomy

Minimally invasive hysterectomy by robotic surgery

Group Type ACTIVE_COMPARATOR

Vaginal or laparoscopic hysterectomy

Intervention Type PROCEDURE

Benign hysterectomy performed by traditional minimal invasive procedures.

Vaginal or laparoscopic hysterectomy

Minimal invasive hysterectomy by vaginal or traditional laparoscopic surgery.

Group Type ACTIVE_COMPARATOR

Robotic hysterectomy

Intervention Type DEVICE

Minimally invasive hysterectomy for benign disorders. Comparing robotic hysterectomy with vaginal hysterectomy and traditional laparoscopic hysterectomy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Robotic hysterectomy

Minimally invasive hysterectomy for benign disorders. Comparing robotic hysterectomy with vaginal hysterectomy and traditional laparoscopic hysterectomy

Intervention Type DEVICE

Vaginal or laparoscopic hysterectomy

Benign hysterectomy performed by traditional minimal invasive procedures.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

da Vinci Surgical system, Intuitive Surgical Inc, CA, USA

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* indication for hysterectomy for benign disease or prophylactic surgery due to hereditary cancer
* size of uterus and vagina allows for retrieval by the vaginal route
* maximum uterine size equivalent to 16 weeks of pregnancy
* informed consent

Exclusion Criteria

* malignant disease
* known extensive intra-abdominal adhesions
* anaesthesiological contraindications to laparoscopic surgery
* women with pacemaker or other implants where electrosurgery is to be avoided
* immunoincompetent women
* simultaneous need for prolapse surgery
* women with known defects of the hemostasis
* allergies towards metronidazole and doxycycline
* inability to understand patient information
Minimum Eligible Age

25 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Region Skane

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jan Persson, MD, PhD

Role: STUDY_DIRECTOR

Department of Obstetrics and Gynecology, Skane University Hospital, Lund

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Obstetrics and Gynecology, Skane University Hospital

Lund, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LundKK

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

RCT on 3 Types of Hysterectomy
NCT05971875 RECRUITING NA